Overview and Scope
Hepatitis C is a viral infection that affects the liver and produces swelling and destruction of the liver tissues over time. The cause of hepatitis C is a viral infection caused by the hepatitis C virus (HCV), a virus that spreads through contaminated blood. The most common way people become infected is through sharing needles or other equipment used to inject drugs.
Sizing and Forecast
The hepatitis c market size has grown rapidly in recent years. It will grow from $59.58 billion in 2023 to $68.25 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to blood transfusion practices, injection drug use, limited treatment options, development of direct-acting antivirals (daas).
The hepatitis c market size is expected to see rapid growth in the next few years. It will grow to $117.94 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to global elimination efforts, improved testing and screening, rising healthcare spending, integration of telemedicine, emerging therapeutic combinations. Major trends in the forecast period include accessible and affordable treatment, focus on high-risk groups, improved drug formulations, collaborative efforts and partnerships, telehealth and digital solutions.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report
Segmentation & Regional Insights
The hepatitis c market covered in this report is segmented -
1) By Type: Chronic Hepatitis C, Acute Hepatitis C, Other Types
2) By Treatment: Antiviral Drugs, Vaccine, Immune Modulator Drugs, Surgery, Other Treatments
3) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
4) By Distribution Channel: Hospital And Retail Pharmacies, Online Pharmacies
5) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Laboratories, Research Institutes, Home Care Settings
North America was the largest region in the hepatitis C market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12582&type=smp
Major Driver Impacting Market Growth
An increase in viral infections is expected to propel the growth of the hepatitis C market going forward. Viral infections refer to infections caused by a virus in the body. Hepatitis C treatment reduces viral infection by eradicating viral infection and restoring immune response in hepatitis C patients after viral clearance. For instance, according to the European Centre for Disease Prevention and Control, a Sweden-based government agency, in 2021, 14,560 cases of hepatitis C were reported in 29 European Economic Area (EEA) member states, which is an increase compared to 13,914 cases reported in the previous year. Therefore, an increase in viral infections is driving the hepatitis C market.
Key Industry Players
Major companies operating in the hepatitis c market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffman La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Sumitomo Corporation, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH., Amgen Inc., Toray Industries Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Lupin Limited, Cadila Healthcare Ltd., LEO Pharma A/S, Biocon Limited, Kadmon Holdings Inc.
The hepatitis c market report table of contents includes:
1. Executive Summary
2. Hepatitis C Market Characteristics
3. Hepatitis C Market Trends And Strategies
4. Hepatitis C Market - Macro Economic Scenario
5. Global Hepatitis C Market Size and Growth
.
.
.
31. Hepatitis C Market Other Major And Innovative Companies
32. Global Hepatitis C Market Competitive Benchmarking
33. Global Hepatitis C Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Hepatitis C Market
35. Hepatitis C Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Global Hepatitis C Treatment Market: OverviewThe demand within the global market for hepatitis C treatment has been rising on account of advancements in the field of healthcare and medicine.
Several new treatment lines for the treatment of hepatitis C have been developed over the past decade.
Henceforth, the global market for hepatitis C treatment has accumulated voluminous revenues over the past decade.
Healthcare professionals have emphasised on the need to develop new treatment lines for hepatitis C. There is no doubt about the fact that the global hepatitis C treatment would accumulate humongous revenues in the years to come.
The emergence of new vendors in the global hepatitis C treatment has also aided market growth.Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=65471The global hepatitis C treatment has been segmented on the basis of the following parameters: treatment type, end user, and region.
Furthermore, new entries have invested in the global hepatitis C treatment market which has in turn given an impetus to the growth of the global market.Request COVID Analysis on Hepatitis C Market –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=65471Global Hepatitis C Treatment Market: Regional OutlookOn the basis of geography, the global market for hepatitis C treatment can be segmented into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific.